ALIM

Alimera Sciences, Inc. ALIM

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALIM SHPH LFCR MNK DERM LSDI ADMP ORGO CYTH ATNX
6M 57.39 % -56.34 % 4.18 % -95.77 % 5.80 % -78.59 % -88.94 % -8.35 % -3.28 % -93.44 %
YTD 35.78 % -84.96 % 1.05 % -95.62 % 100.50 % -80.61 % -93.30 % 41.25 % 20.10 % -94.16 %
1Y 110.65 % -90.38 % 19.75 % -97.80 % 33.67 % -95.22 % -91.44 % 45.08 % -44.14 % -98.12 %
3Y 27.06 % -99.43 % -32.09 % -97.80 % 253.30 % -98.28 % -98.67 % 29.70 % -75.98 % -99.92 %
5Y -5.20 % -99.96 % -31.05 % -97.80 % -15.58 % -98.28 % -99.64 % 17.91 % -95.76 % -99.95 %
10Y -92.70 % -99.96 % -45.28 % -97.80 % -15.58 % -98.28 % -99.82 % -56.10 % -98.80 % -99.92 %
From the beginning -96.64 % -99.96 % -47.22 % -97.80 % -15.58 % -98.28 % -100.00 % -56.10 % -99.39 % -99.92 %

Dividend